215 related articles for article (PubMed ID: 19124749)
21. Folded-back solution structure of monomeric factor H of human complement by synchrotron X-ray and neutron scattering, analytical ultracentrifugation and constrained molecular modelling.
Aslam M; Perkins SJ
J Mol Biol; 2001 Jun; 309(5):1117-38. PubMed ID: 11399083
[TBL] [Abstract][Full Text] [Related]
22. Regulation of complement activation by C-reactive protein: targeting the complement inhibitory activity of factor H by an interaction with short consensus repeat domains 7 and 8-11.
Jarva H; Jokiranta TS; Hellwage J; Zipfel PF; Meri S
J Immunol; 1999 Oct; 163(7):3957-62. PubMed ID: 10490997
[TBL] [Abstract][Full Text] [Related]
23. Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis.
Sharma AK; Pangburn MK
Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10996-1001. PubMed ID: 8855297
[TBL] [Abstract][Full Text] [Related]
24. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway.
Sahu A; Isaacs SN; Soulika AM; Lambris JD
J Immunol; 1998 Jun; 160(11):5596-604. PubMed ID: 9605165
[TBL] [Abstract][Full Text] [Related]
25. Identification and characterization of a major bovine serum tyrosine-O-sulfate-binding protein as a complement factor H.
Sakakibara Y; Suiko M; Fernando PH; Ohashi T; Liu MC
Cytotechnology; 1994; 14(2):97-107. PubMed ID: 7765243
[TBL] [Abstract][Full Text] [Related]
26. Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces.
Ferreira VP; Herbert AP; Hocking HG; Barlow PN; Pangburn MK
J Immunol; 2006 Nov; 177(9):6308-16. PubMed ID: 17056561
[TBL] [Abstract][Full Text] [Related]
27. Structure of complement fragment C3b-factor H and implications for host protection by complement regulators.
Wu J; Wu YQ; Ricklin D; Janssen BJ; Lambris JD; Gros P
Nat Immunol; 2009 Jul; 10(7):728-33. PubMed ID: 19503104
[TBL] [Abstract][Full Text] [Related]
28. Deregulation of Factor H by Factor H-Related Protein 1 Depends on Sialylation of Host Surfaces.
Dopler A; Stibitzky S; Hevey R; Mannes M; Guariento M; Höchsmann B; Schrezenmeier H; Ricklin D; Schmidt CQ
Front Immunol; 2021; 12():615748. PubMed ID: 33732239
[TBL] [Abstract][Full Text] [Related]
29. Disease-associated N-terminal complement factor H mutations perturb cofactor and decay-accelerating activities.
Pechtl IC; Kavanagh D; McIntosh N; Harris CL; Barlow PN
J Biol Chem; 2011 Apr; 286(13):11082-90. PubMed ID: 21270465
[TBL] [Abstract][Full Text] [Related]
30. Mutations in Complement Factor H Impair Alternative Pathway Regulation on Mouse Glomerular Endothelial Cells in Vitro.
Loeven MA; Rops AL; Lehtinen MJ; van Kuppevelt TH; Daha MR; Smith RJ; Bakker M; Berden JH; Rabelink TJ; Jokiranta TS; van der Vlag J
J Biol Chem; 2016 Mar; 291(10):4974-81. PubMed ID: 26728463
[TBL] [Abstract][Full Text] [Related]
31. Molecular modelling of the C-terminal domains of factor H of human complement: a correlation between haemolytic uraemic syndrome and a predicted heparin binding site.
Perkins SJ; Goodship TH
J Mol Biol; 2002 Feb; 316(2):217-24. PubMed ID: 11851332
[TBL] [Abstract][Full Text] [Related]
32. Glomerular basement membrane heparan sulfate in health and disease: A regulator of local complement activation.
Borza DB
Matrix Biol; 2017 Jan; 57-58():299-310. PubMed ID: 27609404
[TBL] [Abstract][Full Text] [Related]
33.
Zhang Y; Wu M; Hang T; Wang C; Yang Y; Pan W; Zang J; Zhang M; Zhang X
Biochem J; 2017 May; 474(10):1619-1631. PubMed ID: 28258151
[TBL] [Abstract][Full Text] [Related]
34. Disturbed sialic acid recognition on endothelial cells and platelets in complement attack causes atypical hemolytic uremic syndrome.
Hyvärinen S; Meri S; Jokiranta TS
Blood; 2016 Jun; 127(22):2701-10. PubMed ID: 27006390
[TBL] [Abstract][Full Text] [Related]
35. Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement.
Kajander T; Lehtinen MJ; Hyvärinen S; Bhattacharjee A; Leung E; Isenman DE; Meri S; Goldman A; Jokiranta TS
Proc Natl Acad Sci U S A; 2011 Feb; 108(7):2897-902. PubMed ID: 21285368
[TBL] [Abstract][Full Text] [Related]
36. Noncovalent PEGylation by polyanion complexation as a means to stabilize keratinocyte growth factor-2 (KGF-2).
Khondee S; Olsen CM; Zeng Y; Middaugh CR; Berkland C
Biomacromolecules; 2011 Nov; 12(11):3880-94. PubMed ID: 21954860
[TBL] [Abstract][Full Text] [Related]
37. Bivalent and co-operative binding of complement factor H to heparan sulfate and heparin.
Khan S; Nan R; Gor J; Mulloy B; Perkins SJ
Biochem J; 2012 Jun; 444(3):417-28. PubMed ID: 22471560
[TBL] [Abstract][Full Text] [Related]
38. A Dimerization Site at SCR-17/18 in Factor H Clarifies a New Mechanism for Complement Regulatory Control.
Dunne OM; Gao X; Nan R; Gor J; Adamson PJ; Gordon DL; Moulin M; Haertlein M; Forsyth VT; Perkins SJ
Front Immunol; 2020; 11():601895. PubMed ID: 33552059
[TBL] [Abstract][Full Text] [Related]
39. Modulation of the proteolytic activity of the complement protease C1s by polyanions: implications for polyanion-mediated acceleration of interaction between C1s and SERPING1.
Murray-Rust TA; Kerr FK; Thomas AR; Wu T; Yongqing T; Ong PC; Quinsey NS; Whisstock JC; Wagenaar-Bos IC; Freeman C; Pike RN
Biochem J; 2009 Aug; 422(2):295-303. PubMed ID: 19522701
[TBL] [Abstract][Full Text] [Related]
40. Localization of the complement-component-C3b-binding site and the cofactor activity for factor I in the 38kDa tryptic fragment of factor H.
Alsenz J; Lambris JD; Schulz TF; Dierich MP
Biochem J; 1984 Dec; 224(2):389-98. PubMed ID: 6240261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
